ARPC1B emerges as an essential oncogenic factor in ccRCC by stimulating EMT and activating the Wnt/β-catenin pathway, ultimately enhancing tumor aggressiveness and metastatic potential. This evidence concerns the gene ARPC1B and nonpapillary renal cell carcinoma.